- Home
- OIS vs RCKT Comparison
OIS vs RCKT Comparison
Compare OIS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | RCKT |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.7M | 534.2M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | OIS | RCKT |
|---|---|---|
| Price | $10.69 | $3.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $14.00 | ★ $29.73 |
| AVG Volume (30 Days) | 759.1K | ★ 4.2M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $5.36 | $64.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $3.33 | $2.19 |
| 52 Week High | $14.50 | $8.26 |
Technical Indicators
Market Signals| Indicator | OIS | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 49.23 |
| Support Level | $5.72 | $2.99 |
| Resistance Level | $12.79 | $4.08 |
| Average True Range (ATR) | 0.49 | 0.28 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 4.27 | 38.43 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.